Carollo, Massimo http://orcid.org/0000-0002-6523-6036
Boccardi, Virginia http://orcid.org/0000-0003-2134-1122
Crisafulli, Salvatore http://orcid.org/0000-0001-6625-1943
Conti, Valeria http://orcid.org/0000-0001-6964-2739
Gnerre, Paola http://orcid.org/0000-0002-1397-6059
Miozzo, Simonetta
Omodeo Salè, Emanuela http://orcid.org/0000-0002-7641-8708
Pieraccini, Fabio
Zamboni, Mauro http://orcid.org/0000-0001-6961-9483
Marengoni, Alessandra http://orcid.org/0000-0002-4851-1825
Onder, Graziano http://orcid.org/0000-0003-3400-4491
Trifirò, Gianluca http://orcid.org/0000-0003-1147-7296
Antonioni, Raffaella
Selleri, Margherita
Vitturi, Giacomo
Filippelli, Amelia
Corrao, Salvatore
Medea, Gerardo
Nobili, Alessandro
Pasina, Luca
Salé, Emanuela Omodeo
Petraglia, Francesco Maria
Poluzzi, Elisabetta
Valle, Alessandro
Vercellone, Adriano
Veronese, Nicola
,
Funding for this research was provided by:
Università degli Studi di Verona
Article History
Received: 22 November 2023
Accepted: 17 December 2023
First Online: 8 March 2024
Declarations
:
: GT has served in the last 3 years on advisory boards/seminars funded by Sanofi, Eli Lilly, AstraZeneca, Abbvie, Novo Nordisk, Gilead, and Amgen; he is also a scientific coordinator of the academic spin-off “INSPIRE srl”, which has received funding for conducting observational studies from several pharmaceutical companies. None of these listed activities is related to the topic of the article. The other authors have no competing interests to declare that are relevant to the content of this article.
: This article does not contain any studies with human participants or animals performed by any authors.
: Not applicable.
: For this type of study, formal consent is not required.